| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8238818 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 8 Pages |
Abstract
Stereotactic radiotherapy boost after EBRT provides excellent local control for patients with NPC. Improved target delineation and dose homogeneity of radiation delivery for both EBRT and SRT is important to avoid long-term complications. Better systemic therapies for distant control are needed.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Wendy M.D., Billy W. M.D., Ph.D., Don R. M.D., Steven D. M.D., John R. M.D., Harlan A. M.D., Willard E. M.D., Michael J. M.D., Nancy J. M.D., Quynh-Thu M.D.,